Pharmaceutical

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity

Bicara was one of three biotechs that went public last week in one of the busiest biotech IPO windows this year.

Sep 18, 2024 - 04:00
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity
Bicara was one of three biotechs that went public last week in one of the busiest biotech IPO windows this year.
Read the original article

Tags:

Previous Article

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy

Next Article

Podcast: How drones are transforming the clinical supply chain in Africa

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ji Xing acquires Biogen’s BIIB131 for acute ischemic stroke

Ji Xing acquires Biogen’s BIIB131 for acute ischemic st...

Jan 13, 2024

LZ-901 by Beijing Luzhu Biotechnology for Herpes Zoster...

May 17, 2024

STAT+: Illumina to lay off 10% of research and development team in bid to cut costs by $100 million

STAT+: Illumina to lay off 10% of research and developm...

Jun 26, 2023